General Information
|
|
Product
|
SERINC5 Antibody FITC
|
Description
|
FITC-Conjugated Serine incorporator 5 Antibody
|
Verified Applications
|
ELISA, IHC, IP, WB
|
Host
|
Rabbit
|
Species Cross Reactivity
|
Human, Monkey
|
Immunogen
|
Synthetic peptide taken within amino acid region 270-320 on human Serine incorporator 5 protein.
|
Accession #
|
NCBI: XP_011541606
|
Physical Properties
|
|
Quantity
|
100 µg
|
Volume
|
200 µl
|
Concentration
|
0.5 µg/µl in antibody stabilization buffer
|
Immunoglobulin
|
IgG
|
Form
|
FITC-Conjugated
|
Clonality
|
Polyclonal
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
ELISA
|
1:10,000
|
Immunohistochemistry |
1:50-1:150 |
Immunoprecipitation
|
1:200
|
Western Blot
|
1:500
|
Protein
|
Uniprot #
|
UPI0005D01C8F
|
Overview
|
Restriction factor required to restrict infectivity of gammaretroviruses, such as HIV-1: acts by inhibiting early step of viral infection and impairing the ability of the viral particle to translocate its content to the cytoplasm (PubMed:26416733, PubMed:26416734). Enhances the incorporation of serine into phosphatidylserine and sphingolipids. May play a role in providing serine molecules for the formation of myelin glycosphingolipids in oligodendrocytes.
|
Molecular Function
|
L-serine transmembrane transporter activity
|
Subcellular Location
|
Cell membrane; Multi-pass membrane
|
Expression
|
Highly expressed in placenta, skeletal muscle, spleen, thymus, testis and peripheral leukocyte and is expressed weakly in the heart, liver and fetal brain.
|
Structure
|
Belongs to the TDE1 family
|
Alternative Nomenclature
|
C5orf12 antibody
SERC5_HUMAN antibody
SERINC5 antibody
Serine incorporator 5 antibody
TPO1 antibody
|
|
|